- Shopping Bag ( 0 items )
-
All (2) from $31.04
-
Used (2) from $31.04
Ships from: Hillside, NJ
Usually ships in 1-2 business days
Ships from: Richmond, TX
Usually ships in 1-2 business days
| Prognostic factors in breast cancer | 3 | |
| Pt. I | Cytomorphometric aspects | |
| Cytomorphometry: A Methodologic study on preparation techniques, selection methods and sample sizes | 35 | |
| Comparison of lightmicroscopic grading and morphometric features in cytological breast cancer specimens | 47 | |
| Prognostic value of nucleolar morphometric variables in cytological breast cancer specimens | 55 | |
| Pt. II | Histomorphometric and morphologic aspects | |
| The morphometric multivariate prognostic index (MPI) is the strongest prognosticator in premenopausal lymph node negative and lymph node positive breast cancer patients | 65 | |
| Prognostic value of proliferation in lymph node metastases of breast cancer patients | 75 | |
| An expert system for histologic typing and grading of invasive breast cancer: First setup | 83 | |
| Pt. III | Syntactic structure analysis | |
| Syntactic structure analysis: An introduction | 93 | |
| Reproducibility and prognostic value of syntactic structure analysis in invasive breast cancer | 99 | |
| The biological background of syntactic structure parameters: An evaluation of correlations with and additional prognostic value to classic, morphometric and DNA cytometric features in invasive breast cancer | 108 | |
| Pt. IV | Quantitation of neu-oncoprotein expression | |
| Quantitation of HER-2/neu oncoprotein overexpression in invasive breast cancer by image analysis: A study comparing fresh and paraffin-embedded material | 119 | |
| Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, morphometric and clinical features in paraffin-embedded invasive breast cancer | 128 | |
| Prediction of response to adjuvant chemotherapy in premenopausal lymph node positive breast cancer patients with morphometry, DNA flow cytometry and HER-2/neu oncoprotein expression: Preliminary results | 143 | |
| Pt. V | The multicenter morphometric mammary carcinoma project | |
| The multicenter morphometric mammary carcinoma project. A nationwide prospective study on reproducibility and prognostic power of routine quantitative assessments in the Netherlands | 157 | |
| Data processing and analysis in the multicenter morphometric mammary carcinoma project (MMMCP) | 168 | |
| Reproducibility of mitosis counting in 2469 breast cancer specimens: Results from the multicenter morphometric mammary carcinoma project | 179 | |
| Pt. VI | General discussion, future prospects and summary | |
| General discussion | 193 | |
| Future perspectives in breast cancer | 197 | |
| Summary | 202 | |
| Subject index | 207 |